Clinical Trials (PDQ®) - National Cancer Institute

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights

	Related Links


	Educational Materials About Clinical Trials Clinical Trials: Questions and Answers Questions to Ask Your Doctor Drug Information from MedlinePlus

Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Basic Trial Information
Trial Description
Summary
Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II

Supportive care, Treatment

Active

Not specified

Other

Levosta-CBF-02/04
NCT00215007

Trial Description

Summary

The purpose of this study is to evaluate the efficacy of levofloxacin to prevent bacterial infections in the postneutropenic period in patients who have undergone allogeneic stem cell transplantation (SCT).

Eligibility Criteria

Inclusion Criteria:

Allogeneic SCT

Postneutropenic period

Written consent

Exclusion Criteria:

Fever

Antibiotic therapy

Neutropenia

Refusal by the patient

Trial Contact Information

Trial Lead Organizations/Sponsors

Charite University Hospital - Campus Virchow Klinikum

Igor Wolfgang Blau, Dr.

Study Chair

Igor Wolfgang Blau, Dr.		Ph: 0049 30 8445 4430
		Email: igor.blau@charite.de

Martin Schmidt-Hieber, Dr.		Ph: 0049 30 8445 4555
		Email: martin.schmidt-hieber@charite.de

Trial Sites

Germany

Berlin

Charite University Hospital - Campus Virchow Klinikum

Igor Wolfgang Blau

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00215007
Information obtained from ClinicalTrials.gov on May 27, 2008

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.